புதுப்பிப்புகள்
டீல்
டீல் மதிப்பு₹25 கோடி
டீல் vs வணிகம்order of ₹25 Cr is >400x Q1 FY27 revenue of ₹0.06 Cr (mega-order anomaly)
செயல்படுத்தும் காலம்1.5 ஆண்டு
அடிப்படை தரம்D
AI முன்கணிப்புகள்
வருவாய் உயர்வு (முதல் ஆண்டு / நிலையான)100.0% / 250.0%
EPS உயர்வு—
அப்சைடு பேஸ் / புல் / பேர்-10.0% / 25.0% / -50.0%
கால எல்லை12-24 மாதங்கள்
உண்மையான சந்தைப் பதிவு
நுழைவு — அடுத்த நாள் தொடக்கம் (01 அக். 2026)₹15.12
சமீபத்திய முடிவு விலை (12 நவ. 2026)₹9.5
தொடங்கியதிலிருந்து வருமானம்-37.2%
α vs Smallcap 250-38.8%
α vs சொந்தத் துறை90+ நாட்கள் வைத்திருந்த பிறகு மட்டுமே காட்டப்படும் — கனரக மின் உபகரணங்கள் இடைநிலை -5.6%, முதிர்ச்சியடைந்த 12 பரிந்துரைகளின் அடிப்படையில்
நேர்மறைகள்
- Secured ₹25 Cr order from Share Medical Care Foundation, establishing an initial project backlog.
- Order scope spans institutional civil renovation (hospital and college campus), an active infrastructure sub-segment.
- Contract is officially designated as arms-length with no promoter interest involved.
அபாயங்கள்
- Severe mega-order execution mismatch: Order value of ₹25 Cr dwarfs Q1 FY27 operational revenue of ₹0.06 Cr (>400x quarterly revenue).
- Massive impending equity dilution: Board has approved raising up to ₹300 Cr via equity/QIP alongside a prior ₹150.79 Cr rights issue, which will heavily dilute current equity holders.
- Severe business model drift: Listed under Heavy Electrical Equipment but undertaking hospital campus civil renovation, suggesting opportunistic pivot rather than core competitive moat.
- Working capital starvation: With negative operating cash flows and -₹0.63 Cr operating loss, financing bank guarantees and materials is a critical bottleneck.
நிர்வாக எச்சரிக்கைகள்
- Postal ballot dated 2026-09-29 seeking shareholder approval for material related-party transactions alongside capital raising.
- Aggressive fundraising approvals (₹300 Cr) completely disproportionate to the current business operational size (₹0.06 Cr quarterly turnover).
- Company recently emerged from financial restructuring with a history of substantial YoY losses.
முழு AI சுருக்கம்
1. Ramp-Aware Catalyst & Financial Math
- Order Value: ₹25.00 crore from Share Medical Care Foundation for campus civil renovation.
- Claimed Execution Window: 6 months (deliverables by March 31, 2027).
- Operational Reality Check: In Q1 FY27 (June 2026), Neueon reported operating revenue of merely ₹0.0609 crore (₹6.1 lakhs) and an operating loss of -₹0.6274 crore. Delivering ₹25 crore of civil renovation in 6 months implies an operational quarterly revenue run-rate of ₹12.50 crore—an expansion of more than 200x over the June 2026 quarter. In civil construction, this is virtually impossible without extensive sub-contracting.
- Realistic Ramp: Civil renovation contracts require 15%–25% in upfront working capital (materials, labor advances, bank guarantees). Given the firm's lack of internal cash generation, execution will realistically stretch over 18 to 24 months (1.5 years).
- Revenue & Margin Profile: Assuming ₹12–15 crore is recognized over 12 months (subject to funding), typical blended EBITDA margins for civil renovation contractor work range between 6% and 8%. At an 8% EBITDA margin on ₹15 crore, EBITDA would be ₹1.20 crore. After accounting for corporate overheads, interest, and depreciation, net earnings contribution would remain minimal (PAT < ₹0.40 crore), translating to negligible per-share EPS once impending dilution takes effect.
2. தொழில்துறைச் சூழல் & மூலதனத் தீவிரம்
- Sector Dynamics: While officially classified under 'Heavy Electrical Equipment', this announcement represents a complete diversion into institutional civil renovation.
- Capital Intensity & Working Capital: Civil contracting is highly working-capital intensive. Structural growth for institutional civil construction stands at ~10%–12% CAGR, but fragmented competition and milestone-based certification frequently trap cash in retention money and receivables.
3. மல்டிபேக்கர் தர மதிப்பீடு
- EPS & Revenue Trajectory: Deeply impaired. Q1 FY27 operational revenue collapsed YoY from ₹4.45 crore to ₹0.06 crore. Net loss narrowed from -₹22.08 crore to -₹0.91 crore primarily via debt restructuring rather than organic operational profitability.
- Capital Structure & Dilution Risk: The company has approved equity fundraising of up to ₹300 crore via postal ballot (September 2026) and previously pursued a ₹150.79 crore rights issue. Raising this quantum of capital relative to a penny-stock market cap will cause massive dilution, severely compressing any per-share earnings expansion.
- Governance Concerns: Approval sought for material related-party transactions in the September 29, 2026 postal ballot notice raises critical flags regarding corporate governance and capital allocation.
4. மதிப்பீடு & சூழல் அளவுத்திருத்தம்
- Current Price: ₹15.10. Trailing P/E is not calculable due to negative earnings.
- Bull Case (+25%, Target ₹18.90): The company secures customer advances, sub-contracts the civil works effectively, avoids predatory equity dilution, and establishes operational EBITDA profitability by FY28.
- Base Case (-10%, Target ₹13.60): Contract experiences delays due to working capital constraints; execution stretches past FY27; impending equity issuances heavily dilute EPS.
- Bear Case (-50%, Target ₹7.55): Inability to furnish required bank guarantees leads to contract cancellation; large equity dilution at steep discounts depresses stock price.
5. தீர்ப்பின் காரணம்
Neueon Corporation exhibits classic turnaround/penny-stock risks: a mega-order relative to current revenue (>400x quarterly sales) in an unrelated line of business, lack of operational scale, ongoing net losses, and impending massive equity dilution (₹300 crore). It does not meet Minervini SEPA criteria for high-conviction fundamental leadership.
2026-09-30 நிலவரப்படி பகுப்பாய்வு (விலை ₹15.06) · AI ஆய்வு, முதலீட்டு ஆலோசனை அல்ல.
பின்தொடர்Telegram
